Sangamo Therapeutics's banner

Sangamo Therapeutics

@SangamoTx • 4,208 subscribers

Committed to translating our ground-breaking science into genomic medicines that transform patients’ lives.

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Today we are very pleased to announce alignment with the U.S. FDA on an Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry, accelerating estimated time to potential approval by approx. 3 yrs. Learn more:

Today we are very pleased to announce alignment with the U.S. FDA on an Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry, accelerating estimated time to potential approval by approx. 3 yrs. Learn more:

Sangamo Therapeutics

40,635 просмотров • 1 год назад

Today, we announce progress in our Fabry disease program, achieving important derisking milestones in our pathway to anticipated BLA submission. Learn more:

Today, we announce progress in our Fabry disease program, achieving important derisking milestones in our pathway to anticipated BLA submission. Learn more:

Sangamo Therapeutics

16,983 просмотров • 1 год назад

We’re proud to share that all our abstracts were accepted to #ASGCT2025 —including three oral presentations, with our prion data selected for the prestigious #PresidentialSymposium. Click here to learn more: #ASGCT #genomicmedicine #neurology #Innovation

We’re proud to share that all our abstracts were accepted to #ASGCT2025 —including three oral presentations, with our prion data selected for the prestigious #PresidentialSymposium. Click here to learn more: #ASGCT #genomicmedicine #neurology #Innovation

Sangamo Therapeutics

15,155 просмотров • 1 год назад

Больше нет контента для загрузки